NBIS · Categories · M&A
NBIS - Mergers and acquisitions
Nebius Group N.V. (NBIS) mergers and acquisitions - real-time wire coverage filtered to M&A only.
Recent M&A for NBIS
- Nebius acquires Inferize to strengthen Nebius Token Factory's production inference stackBrings technology that cuts time to launch and scale large AI models, improving token economics and capacity utilization Adds deeply experienced systems engineering talent to Nebius's inference team Continues production inference build-out on Nebius with optimizations across the stack Nebius (NASDAQ:NBIS), the AI cloud company, today announced it has acquired Inferize, an inference optimization company whose technology shortens the time needed to launch and scale large AI models, making inference workloads elastic. Inferize's technology and team have joined Nebius Token Factory, Nebius's managed inference platform for production AI. Cold starts – the time models need to load b
- Report Highlights Growth in AI Biomarker Monitoring as Industry Giant's GPUs Power Next-Gen PlatformMarketNewsUpdates News Commentary NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The global Diagnostic Biomarker market is experiencing unprecedented growth and is projected to continue to see substantial growth in years to come. A recent report from the (NIH) National Library of Medicine discussed the AI-Assisted Biomarker, said that: "Recently, advancements in healthcare digitization and personalized treatments have led to groundbreaking developments. Utilization of AI and ML has the potential to enhance comprehension of disease onset and progression, potentially uncovering new disease subtypes, unveiling novel drug targets, advancing the field of precision medicine, propelling efforts towards d